Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Japan Pediatric Society's Scientific Meeting
May 22, 2006
- Mr Nogimori Wants to Make
May 22, 2006
- REGULATORY NEWS IN BRIEF
May 22, 2006
- SURVEY 3 articles
May 22, 2006
- NEW PRODUCTS
May 22, 2006
- Tanabe Seiyaku Announces
May 22, 2006
- Eisai Starts PI Trial for
May 22, 2006
- Daiichi Sankyo: Olmesartan
May 22, 2006
- CPHI JAPAN 2006
May 22, 2006
- Banyu to Focus on Basic Research,
May 15, 2006
- R&D NEWS IN BRIEF
May 15, 2006
- New Drug Improves Quality of Sleep: Rohto
May 15, 2006
- Abbott Acquires Guidant Vascular Business
May 15, 2006
- Astellas Licenses Anemia
May 15, 2006
- Morimoto-Iyaku Establishes
May 15, 2006
- Novartis Pharma Integrates Marketing Systems
May 15, 2006
- MEDICAL DEVICE NEWS IN BRIEF
May 15, 2006
- BUSINESS NEWS IN BRIEF
May 15, 2006
- ANNUAL BUSINESS RESULTS
May 15, 2006
- ANNUAL BUSINESS RESULTS
May 15, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…